The Right to Know: A Revised Standard for Reporting Incidental Findings

被引:14
|
作者
Schaefer, G. Owen [1 ]
Savulescu, Julian [2 ,3 ,4 ,5 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Biomed Eth, Singapore, Singapore
[2] Univ Oxford, Pract Eth, Oxford, England
[3] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford, England
[4] Murdoch Childrens Res Inst, Biomed Eth, Melbourne, Vic, Australia
[5] Univ Melbourne, Law, Melbourne, Vic, Australia
关键词
INFORMED-CONSENT; GENETIC RESEARCH; CLINICAL EXOME; RECOMMENDATIONS; PARTICIPANTS; AUTONOMY; PERSPECTIVES; EXPECTATIONS; RESEARCHERS; IGNORANCE;
D O I
10.1002/hast.836
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
During the course of biomedical research, researchers sometimes obtain information on participants that is outside the aim of the study but may nonetheless be relevant to the participants. These incidental findings, as they are known, have been the focus of a substantial amount of discussion in the bioethics literature, and a consensus has begun to emerge about what researchers should do in light of the possibility of incidental findings. A consensus, however, is not necessarily correct. In this article, we address the common view that reporting of incidental findings should be based primarily on the possibility of medical benefit, factoring in the findings' validity, clinical actionability, and significance to health or reproduction. While such medical beneficence should not be discarded, the need to give proper attention to participants' autonomy, privacy, and interests (especially considering discussion of participants' right not to know) suggests an alternative standard for when to report incidental findings: even if they are of no direct medical benefit, incidental findings should be reported based on the extent to which the participant can be expected to comprehend the information. We will offer a preliminary defense of this alternative as best respecting participants' autonomy and privacy and promoting their interests. However, we acknowledge that the standard would face significant practical barriers, and these barriers lead us to propose a metaconsent addendum that would allow subjects to essentially waive the comprehension standard when resource or other constraints make meeting it impracticable.
引用
收藏
页码:22 / 32
页数:11
相关论文
共 50 条
  • [31] Key emerging themes for assessing the cost-effectiveness of reporting incidental findings
    Phillips, Kathryn A.
    Ladabaum, Uri
    Pletcher, Mark J.
    Marshall, Deborah A.
    Douglas, Michael P.
    GENETICS IN MEDICINE, 2015, 17 (04) : 314 - 315
  • [32] Re: "Rethinking Normal: Benefits and Risks of Not Reporting Harmless Incidental Findings" Reply
    Pandharipande, Pari V.
    Herts, Brian R.
    Gore, Richard M.
    Mayo-Smith, William W.
    Harvey, H. Benjamin
    Megibow, Alec J.
    Berland, Lincoln L.
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2016, 13 (09) : 1025 - 1027
  • [33] On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing
    May, Thomas
    JOURNAL OF LAW MEDICINE & ETHICS, 2015, 43 (01): : 134 - 142
  • [34] A framework designed to improve the evaluation and reporting of incidental findings in clinical genomic tests
    Brown, Carolyn
    Chandrasekhar, Anjana
    Coffey, Alison
    Perry, Denise
    Taft, Ryan
    Thorpe, Erin
    Hagelstrom, R. Tanner
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S218 - S219
  • [35] Towards a European consensus for reporting incidental findings during clinical NGS testing
    Jayne Y Hehir-Kwa
    Mireille Claustres
    Ros J Hastings
    Conny van Ravenswaaij-Arts
    Gabrielle Christenhusz
    Maurizio Genuardi
    Béla Melegh
    Anne Cambon-Thomsen
    Philippos Patsalis
    Joris Vermeesch
    Martina C Cornel
    Beverly Searle
    Aarno Palotie
    Ettore Capoluongo
    Borut Peterlin
    Xavier Estivill
    Peter N Robinson
    European Journal of Human Genetics, 2015, 23 : 1601 - 1606
  • [36] Variation in Reporting of Incidental Findings on Lung Cancer Screening and Association with Subsequent Assessment
    Atoma, B.
    Fabbrini, A. E.
    Clothier, B.
    Campbell, M. E.
    Melzer, A. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [38] Searching for secondary findings: considering actionability and preserving the right not to know
    Isidor, Bertrand
    Julia, Sophie
    Saugier-Veber, Pascale
    Weil-Dubuc, Paul-Loup
    Bezieau, Stephane
    Bieth, Eric
    Bonnefont, Jean-Paul
    Munnich, Arnold
    Bourdeaut, Franck
    Bourgain, Catherine
    Chassaing, Nicolas
    Corradini, Nadege
    Haye, Damien
    Plaisancie, Julie
    Dupin-Deguine, Delphine
    Calvas, Patrick
    Mignot, Cyril
    Cogne, Benjamin
    Manouvrier, Sylvie
    Pasquier, Laurent
    Heron, Delphine
    Boycott, Kym M.
    Turrini, Mauro
    Vears, Danya F.
    Nizon, Mathilde
    Vincent, Marie
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 (10) : 1481 - 1484
  • [39] Searching for secondary findings: considering actionability and preserving the right not to know
    Bertrand Isidor
    Sophie Julia
    Pascale Saugier-Veber
    Paul-Loup Weil-Dubuc
    Stéphane Bézieau
    Eric Bieth
    Jean-Paul Bonnefont
    Arnold Munnich
    Franck Bourdeaut
    Catherine Bourgain
    Nicolas Chassaing
    Nadège Corradini
    Damien Haye
    Julie Plaisancie
    Delphine Dupin-Deguine
    Patrick Calvas
    Cyril Mignot
    Benjamin Cogné
    Sylvie Manouvrier
    Laurent Pasquier
    Delphine Héron
    Kym M Boycott
    Mauro Turrini
    Danya F. Vears
    Mathilde Nizon
    Marie Vincent
    European Journal of Human Genetics, 2019, 27 : 1481 - 1484
  • [40] searching for secondary findings, considering actionability and preserving the right not to know
    Vincent, M.
    Nizon, M.
    Julia, S.
    Bezieau, S.
    Cogne, B.
    Pasquier, L.
    Isidor, B.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1807 - 1807